Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative ( <scp>HR</scp> +/ <scp>HER2</scp> −) Advanced Breast Cancer Treated With Palbociclib in the <scp>POLARIS</scp> Study
- DOI
- 10.1002/cam4.71788
- Published
- 2026-04
- Container
- Cancer Medicine
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.71788,
title = {Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative (
<scp>HR</scp>
+/
<scp>HER2</scp>
−) Advanced Breast Cancer Treated With Palbociclib in the
<scp>POLARIS</scp>
Study},
author = {Debu Tripathy and Joanne L. Blum and Meghan S. Karuturi and Steven McCune and Sobha Kurian and Mehdi M. Moezi and Daniel M. Anderson and Yan Ji and Timothy J. Pluard and John Migas and Shailendra Lakhanpal and Erin Jepsen and Yao Wang and Monica Z. Montelongo and Zhe Zhang and Joseph C. Cappelleri and Eric Gauthier and Gabrielle B. Rocque},
year = {2026},
journal = {Cancer Medicine},
doi = {10.1002/cam4.71788},
url = {https://doi.org/10.1002/cam4.71788}
}RIS
TY - JOUR
TI - Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative (
<scp>HR</scp>
+/
<scp>HER2</scp>
−) Advanced Breast Cancer Treated With Palbociclib in the
<scp>POLARIS</scp>
Study
AU - Debu Tripathy
AU - Joanne L. Blum
AU - Meghan S. Karuturi
AU - Steven McCune
AU - Sobha Kurian
AU - Mehdi M. Moezi
AU - Daniel M. Anderson
AU - Yan Ji
AU - Timothy J. Pluard
AU - John Migas
AU - Shailendra Lakhanpal
AU - Erin Jepsen
AU - Yao Wang
AU - Monica Z. Montelongo
AU - Zhe Zhang
AU - Joseph C. Cappelleri
AU - Eric Gauthier
AU - Gabrielle B. Rocque
PY - 2026
JO - Cancer Medicine
DO - 10.1002/cam4.71788
UR - https://doi.org/10.1002/cam4.71788
ER - APA
Tripathy, D., Blum, J. L., Karuturi, M. S., McCune, S., Kurian, S., Moezi, M. M., Anderson, D. M., Ji, Y., Pluard, T. J., Migas, J., Lakhanpal, S., Jepsen, E., Wang, Y., Montelongo, M. Z., Zhang, Z., Cappelleri, J. C., Gauthier, E., & Rocque, G. B. (2026). Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative ( <scp>HR</scp> +/ <scp>HER2</scp> −) Advanced Breast Cancer Treated With Palbociclib in the <scp>POLARIS</scp> Study. Cancer Medicine. https://doi.org/10.1002/cam4.71788
Source records
- crossref · retrieved 2026-09-26T00:26:16.213Z